Savannah has been my new favorite nurse--so patient, kind, and attentive
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and [PMID: 42311743] Laboratory literature summary: Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and laboratory Outcomes
Horsch D, Goke R, Eissele R, Michel B, and Goke B
Psychiatry Res Neuroimaging
3.2 Effect of liraglutide on food and water intake, body composition and glycaemia In addition to its insulinotropic action, GLP-1 has also been shown to reduce food intake and slow gastric emptying (27)
De cara a evitar confusiones en la prctica clnica diaria, es importante puntualizar que liraglutida 3 mg y semaglutida 2,4 mg pueden utilizarse en pacientes con DT2, siempre y cuando estos presenten obesidad o sobrepeso ms comorbilidades